Download ‘Regulatory Intelligence 5’ from Acorn Regulatory
We have published our latest e-book ‘Regulatory Intelligence 5’. This edition features a number of new articles from our expert staff. The articles look at a range of issues, many of the topics were suggested by clients or visitors to our website.
In this edition we look at the following topics:
Pharmaceutical Development for Historic Dossiers
Good Pharmacovigilance Practice (GvP) & Social Media
The EU MDR & The Authorised Representative
Advice for Companies Attending Scientific Advice Meetings
What You Need To Know About MRP Grouped Variations
You can download the ‘Regulatory Intelligence 5‘ by completing your details below.
Acorn Regulatory publishes regular e-books and whitepapers on issues related to regulatory affairs, pharmacovigilance, quality compliance and much more. Our whitepapers have been downloaded tens of thousands of times by specialists throughout the world.
No Deal Brexit Whitepaper
Some of our most recent publications include our ‘no deal’ Brexit whitepaper. ‘What Happens Next?’, published earlier this year, considers the impact of the UK leaving the EU without a deal on October 31st. The whitepaper, which has been downloaded thousands of times since publication, looks at the impact that might be felt by companies in the life sciences sector.
You can download your copy of ‘What Happens Next? here.
Are You Ready for MDR?
The new medical device regulations are scheduled to come into force on May 26th 2020. Between now and then, companies in the device sector have many issues to consider. Who will act as the Person Responsible for Regulatory Compliance? What are the new responsibilities of an EU Authorised Representative under the more stringent MDR? These, and others, need to be considered by device manufacturers and their trading partners. This whitepaper looks at those issues. Get your copy here.